Concept:
Portal hypertension is a pathological increase in the blood pressure within the portal venous system resulting from increased vascular resistance (prehepatic, intrahepatic, or posthepatic) and increased splanchnic blood flow.
The Hepatic Venous Pressure Gradient (HVPG) represents the gold-standard measurement of portal pressure, calculated as the difference between the Wedged Hepatic Venous Pressure (WHVP) and the Free Hepatic Venous Pressure (FHVP).
Explanation:
• The normal physiological HVPG ranges between $1\text{ and 5\text{ mmHg}$}.
• An HVPG $>5\text{ mmHg}$ defines the presence of mild/subclinical portal hypertension.
• However, Clinically Significant Portal Hypertension (CSPH) is universally defined in clinical hepatology as an $\text{HVPG \ge 10\text{ mmHg}$ (or $10\text{--}12\text{ mmHg}$)}.
• At an HVPG threshold of $\ge 10\text{ mmHg}$, portosystemic collateral vessels develop, manifesting as gastroesophageal varices, splenomegaly, and ascites.
• When the HVPG reaches $\ge 12\text{ mmHg}$, the critical threshold for acute variceal rupture and life-threatening gastrointestinal hemorrhage is reached.
• In pediatric practice, Extrahepatic Portal Vein Obstruction (EHPVO) is the most common cause of prehepatic portal hypertension (where HVPG is typically normal because the block is presinusoidal, but direct portal vein pressure exceeds $10\text{--}12\text{ mmHg}$).
Final Answer:
Clinically significant portal hypertension associated with variceal development is defined when the HVPG exceeds 10–12 mmHg.